SARS and common viral infections.
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS.
Louie
Janice K
JK
California Emerging Infections Program, California Department of Health Services, Berkeley, 94704, USA. JLouie@dhs.ca.gov
Hacker
Jill K
JK
Mark
Jennifer
J
Gavali
Shilpa S
SS
Yagi
Shigeo
S
Espinosa
Alex
A
Schnurr
David P
DP
Cossen
Cynthia K
CK
Isaacson
Erin R
ER
Glaser
Carol A
CA
Fischer
Marc
M
Reingold
Arthur L
AL
Vugia
Duc J
DJ
D000914:Antibodies, Viral / Q000097:blood; D002140:California; D006801:Humans; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000821:virology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D045473:Severe acute respiratory syndrome-related coronavirus / Q000302:isolation & purification; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis* / Q000821:virology; D014777:Virus Diseases / Q000175:diagnosis* / Q000821:virology
D000914:Antibodies, Viral; D012367:RNA, Viral